(Q37933190)

25 August 2017

1 reference

title

Current and future needs for developmental toxicity testing (English)

1 reference

25 August 2017

Susan L Makris

1

1 reference

25 August 2017

James H Kim

2

1 reference

25 August 2017

Amy Ellis

3

1 reference

25 August 2017

Willem Faber

4

1 reference

25 August 2017

Wafa Harrouk

5

1 reference

25 August 2017

Joseph M Lewis

6

1 reference

25 August 2017

Merle G Paule

7

1 reference

25 August 2017

Jennifer Seed

8

1 reference

25 August 2017

Melissa Tassinari

9

1 reference

25 August 2017

Rochelle Tyl

10

1 reference

25 August 2017

15 September 2011

1 reference

Birth Defects Research Part B: Developmental and Reproductive Toxicology

25 August 2017

1 reference

25 August 2017

92

1 reference

25 August 2017

5

1 reference

25 August 2017

384-394

1 reference

Critical evaluation of current developmental toxicity testing strategies: a case of babies and their bathwater

25 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

A tiered approach to life stages testing for agricultural chemical safety assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

The ToxCast program for prioritizing toxicity testing of environmental chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

Cancer risk in women exposed to diethylstilbestrol in utero.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

The toxicity data landscape for environmental chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

Developmental toxicity testing for safety assessment: new approaches and technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

In vitro and other alternative approaches to developmental neurotoxicity testing (DNT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

Terminology of developmental abnormalities in common laboratory mammals (Version 2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

Alternative methods for developmental toxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

Terminology of developmental abnormalities in common laboratory mammals (version 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

The FDA critical path initiative and its influence on new drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20335

21 January 2018

Identifiers

DOI

10.1002/BDRB.20335

1 reference

25 August 2017

1 reference